Literature DB >> 2040281

Comparison of multiple forms of the high mobility group I proteins in rodent and human cells. Identification of the human high mobility group I-C protein.

V Giancotti1, A Bandiera, E Buratti, A Fusco, R Marzari, B Coles, G H Goodwin.   

Abstract

The class I of the high mobility group (HMG) proteins is formed by phosphoproteins which are associated with AT-rich DNA sequences in the nucleus. Three HMGI proteins have previously been described in proliferating rodent cells (HMG Y, HMG I and HMGI-C). All three proteins exhibit microheterogeneity. The microheterogeneity of mouse HMG Y has been investigated in detail and shown to be due to phosphorylation of the protein which is sensitive to alkaline-phosphatase treatment. HMG I is similarly modified. Human cells have up to now only been found to contain HMG Y and HMG I. A search for the third protein, HMGI-C, in human cells was carried out and the protein was found in a hepatoma cell line, but not in normal or transformed T-cells. This HMGI-C protein was found to be modified by phosphorylation, part of which was found to be phosphatase insensitive. An unexpected additional finding in this study was that human cells contain two HMG17 proteins which differ in their N-terminal primary sequences.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2040281     DOI: 10.1111/j.1432-1033.1991.tb16003.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  16 in total

1.  Microheterogeneous Cytosolic High-Mobility Group Proteins from Broccoli Co-Purify with and Are Phosphorylated by Casein Kinase II.

Authors:  L. J. Klimczak; A. R. Cashmore
Journal:  Plant Physiol       Date:  1994-07       Impact factor: 8.340

2.  cDNA cloning of the HMGI-C phosphoprotein, a nuclear protein associated with neoplastic and undifferentiated phenotypes.

Authors:  G Manfioletti; V Giancotti; A Bandiera; E Buratti; P Sautière; P Cary; C Crane-Robinson; B Coles; G H Goodwin
Journal:  Nucleic Acids Res       Date:  1991-12-25       Impact factor: 16.971

3.  NF-kappaB mediated transcriptional activation is enhanced by the architectural factor HMGI-C.

Authors:  F Mantovani; S Covaceuszach; A Rustighi; R Sgarra; C Heath; G H Goodwin; G Manfioletti
Journal:  Nucleic Acids Res       Date:  1998-03-15       Impact factor: 16.971

Review 4.  The High Mobility Group A1 (HMGA1) Transcriptome in Cancer and Development.

Authors:  T F Sumter; L Xian; T Huso; M Koo; Y-T Chang; T N Almasri; L Chia; C Inglis; D Reid; L M S Resar
Journal:  Curr Mol Med       Date:  2016       Impact factor: 2.222

5.  Expression of HMGI-C and HMGI(Y) in ordinary lipoma and atypical lipomatous tumors: immunohistochemical reactivity correlates with karyotypic alterations.

Authors:  G Tallini; P Dal Cin; K J Rhoden; G Chiapetta; G Manfioletti; V Giancotti; A Fusco; H Van den Berghe; R Sciot
Journal:  Am J Pathol       Date:  1997-07       Impact factor: 4.307

6.  Inhibition of HMGI-C protein synthesis suppresses retrovirally induced neoplastic transformation of rat thyroid cells.

Authors:  M T Berlingieri; G Manfioletti; M Santoro; A Bandiera; R Visconti; V Giancotti; A Fusco
Journal:  Mol Cell Biol       Date:  1995-03       Impact factor: 4.272

7.  Calcium-dependent ADP-ribosylation of high-mobility-group I (HMGI) proteins.

Authors:  V Giancotti; A Bandiera; C Sindici; L Perissin; C Crane-Robinson
Journal:  Biochem J       Date:  1996-08-01       Impact factor: 3.857

8.  Architectural transcription factor HMGI(Y) promotes tumor progression and mesenchymal transition of human epithelial cells.

Authors:  R Reeves; D D Edberg; Y Li
Journal:  Mol Cell Biol       Date:  2001-01       Impact factor: 4.272

9.  Gene expressions of HMGI-C and HMGI(Y) are associated with stage and metastasis in colorectal cancer.

Authors:  Meng-Lin Huang; Chou-Chan Chen; Li-Ching Chang
Journal:  Int J Colorectal Dis       Date:  2009-07-17       Impact factor: 2.571

10.  Derepression of HMGA2 gene expression in retinoblastoma is associated with cell proliferation.

Authors:  Kai-Yin Chau; Guidalberto Manfioletti; Kam-Wa Cheung-Chau; Alfredo Fusco; Nathalie Dhomen; Jane C Sowden; Tetsuo Sasabe; Shizuo Mukai; Santa Jeremy Ono
Journal:  Mol Med       Date:  2003 May-Aug       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.